Christopher A. Scott - 22 Jan 2023 Form 4 Insider Report for Matson, Inc. (MATX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 Jan 2023, 16:39:54 UTC
Prior SEC filing
09 Jun 2022
Next SEC filing
27 Jan 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christopher A. Scott

Key filing fact

Christopher A. Scott filed Form 4 for Matson, Inc. (MATX) on 23 Jan 2023.

Key facts

  • This page summarizes Christopher A. Scott's Form 4 filing for Matson, Inc. (MATX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 23 Jan 2023, 16:39.

Change

  • Previous filing in this sequence was filed on 09 Jun 2022.
  • Current net transaction value: -$15,299.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MATX transaction

Common Stock

Tax liability

Transaction value
$15,299
Shares
-241
Change %
-2.4%
Price
$63.48
Shares after
9,832
Date
22 Jan 2023
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents common stock withheld by the Issuer to cover tax withholding obligations arising from the vesting of a previous grant of restricted stock units.

Footnote F2

Includes shares acquired under a Dividend Reinvestment Program exempt pursuant to Rule 16a-11 and a Qualified Plan exempt pursuant to Rule 16a-3(f)(1)(i)(B).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .